SCHEMBL4780428

SCHEMBL4780428

C1=Nc2ccccc2Oc2cccc(N3CCNCC3)c21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 6/20 0.48
HTR1A P08908 4/20 0.45
HTR6 P50406 4/20 0.45
HTR3A P46098 3/20 0.45
HTR2A P28223 3/20 0.45
HTR7 P34969 3/20 0.45
HTR5A P47898 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2D6 P10635 2/20 0.45
TSHR P16473 2/20 0.45
NFKB1 P19838 2/20 0.45
MTOR P42345 2/20 0.45
HTR3E A5X5Y0 1/20 0.45
HTR3B O95264 1/20 0.45
NCF1 P14598 1/20 0.45
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
HTR3D Q70Z44 1/20 0.45
HTR3C Q8WXA8 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9080717 0.95 ADRB1 (0.44) ADRB1HTR1AHTR6HTR3AHTR2A
SCHEMBL4796942 0.84 HTR1A (0.45) ADRB1HTR1AHTR6HTR3AHTR2A
SCHEMBL5936585 0.84 HTR1A (0.46) ADRB1HTR1AHTR6HTR3AHTR2A
SCHEMBL5936587 0.84 ADRB1 (0.42) ADRB1HTR1AHTR6HTR3AHTR2A
SCHEMBL5936566 0.84 ADRB1 (0.49) ADRB1HTR1AHTR6HTR3AHTR2A
SCHEMBL3685628 0.83 HRH4 (0.51) HTR1AHTR6HTR3AHTR2AHTR7
Hydrochloric Acid SCHEMBL5606159 0.82 HRH4 (0.50) HTR1AHTR6HTR3AHTR2AHTR7
SCHEMBL5971687 0.80 KDM4E (0.46) HTR6KDM4EALDH1A1DRD2DRD3
SCHEMBL7256282 0.80 HRH4 (0.45) HTR6TSHRKDM4EALDH1A1TRPA1
SCHEMBL6029951 0.79 HTR1A (0.44) ADRB1HTR1AHTR6HTR3AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021463-A2 AMINO SUBSTITUTED DIARYL[A,D]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS ACADIA PHARMACEUTICALS, INC. (US) 2008-02-21 WO claimed
WO-1996018623-A1 BENZYL-SUBSTITUTED COMPOUNDS HAVING DOPAMINE RECEPTOR AFFINITY ALLELIX BIOPHARMACEUTICALS INC. (US) 1996-06-20 WO disclosed
WO-1996018621-A1 ALKYL-SUBSTITUTED COMPOUNDS HAVING DOPAMINE RECEPTOR AFFINITY ALLELIX BIOPHARMACEUTICALS INC. (US) 1996-06-20 WO disclosed